Fluxome Sciences' Asset Sale

Fluxome Sciences raised a round of funding on November 29, 2012. Investors include Evolva Holding.

Fluxome uses its microbial metabolic engineering technology platform to build cell factories for the production of a range of nutraceutical ingredients.…

Articles about Fluxome Sciences' Asset Sale: